当前位置: 首页 > 期刊 > 《中国实用医药》 > 2009年第7期 > 正文
编号:11768454
三项肿瘤标记物测定在附件包块中的临床价值(1)
http://www.100md.com 2009年3月5日 沈亚杰
第1页

    参见附件(1504KB,2页)。

     【摘要】 目的 探讨CA-125,CA-199,CEA测定在附件包块中的临床价值。方法 测定157例附件包块患者及40例健康人的CA-125,CEA,CA-199值。结果 卵巢癌组CA-125,CEA,CA-199值与良性附件包块各组及健康人组比较均有显著性差异(P<0.01),子宫内膜异位症,附件炎性包块组CA-125值与健康人组比较有显著性差异(P<0.01),良性附件包块各组CEA,CA-199值与健康人组比较均无显著性差异(P>0.05),三项联检卵巢癌总阳性率为96.8%。结论 CA-125,CEA,CA-199是卵巢癌重要的相关抗原,在良恶性附件包块鉴别诊断中有重要意义, 三项联检是一种早期诊断卵巢癌有效的方法。

    【关键词】 肿瘤标记物;附件包块

    The clinical value of three kinds of tumor markers in patients with adnexal masses

    SHENYa-jie.

    Department of Obstetric and Gynecology, the Affiliated Zhenjiang First People’s Hospital of Jiangsu University,Jiangsu212002,China

    

    【Abstract】 Objective To investigate the clinical value of three kinds of tumor markers in patients with adnexal masses. Methods 157 cases of adnexal masses and 40 cases of normal human were measured cancer antigen 125(CA-125),canbodydrate antigen 199(CA-199) and carcinoembryonic antigen(CEA) with immunoradiologic method. Result The level of CA-125, CA-199 and CEA in patients with ovarian cancer were significantly higher than that in patients with benignant adnexal masses and normal human(P<0.01). The level of CA-125 in patients with endometriosis , adnexal inflammation masswas significantly higher than that in normal human(P<0.01). There was no statistically significant difference in the level of CA-199 and CEA in patients with benignant adnexal masses and normal human(P>0.05).If all the result of CA-125, CA-199 and CEA were put together,the positive rate of patients with ovarian cancer was 96.8%. Conclusion CA-125,CEA,CA-199 were important antigen Of ovarian cancer. CA-125,CEA,CA-199 have greater values in differentiation diagnosis in patients with m alignant adnexal masses from benignant adnexal masses.Combained assays of three tumor markers is one of the effective methods for diagnosis of ovarian cancer in early term.

    【Key words】 Tumor marker;Adnexal masse

    附件包块的性质的诊断,术前十分复杂。其良恶性的鉴别是一个难题。本文对2006年1月至2008年1月本院妇科收治的附件包块患者中抽取157例,术前进行肿瘤标记物的测定,其均手术治疗,术后予以病理确诊,将其术前肿瘤标记物的测定结果进行统计学分析。

    1 临床资料

    1.1 检测对象 2006年1月至2008年1月在本院妇科收治的经手术病理证实的157例附件包块病例。对照组40例为其体征,妇科检查无异常,HBsAg阴性的健康妇女,年龄25~62岁。卵巢良性肿瘤患者55例,年龄21~69岁, 卵巢癌患者32例,年龄35~67岁,卵巢子宫内膜异位症患者30例,年龄27~47岁,附件炎性包块患者40例,年龄28~49岁。

    1.2 方法 抽取患者空腹血2 ml,分离血清,由我院同位素室进行检测。由北京科大创新有限公司中佳分公司生产的GC-1500放射免疫计数仪,用放射免疫方法分析测定,正常参考值CA-125 <35 U/ml, CA-199<30 U/ml,CEA<15 ng/ml,所有病例均进行手术,予以病理学检测确诊。

    1.3 统计学分析 统计学处理各测定值以均数±标准(x±s)差表示,采用t检验,率比较采用χ2检验, P<0.05有显著性差异。

    2 结果

    卵巢癌组CA-125值与其他各组比较均有显著性差异(P<0 ......

您现在查看是摘要介绍页,详见PDF附件(1504KB,2页)